Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Is ABBV A Good Stock To Buy Right Now?’

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

In A Blow To AbbVie Inc (ABBV) Humira, Market For Biosimilars Opened Wide

Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court. The ruling was in favor......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AbbVie Inc (ABBV) In Share Buyback Plan For The Third Year In A Row

The AbbVie Inc (NYSE:ABBV) board of directors has given the authorization required to increase $5 billion to the company’s existing share buyback program......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

UK National Institute For Health And Care Excellence Rejects Leukemia Drug From AbbVie Inc (ABBV)

The National Institute for Health and Care Excellence has refused to authorize AbbVie Inc (NYSE:ABBV)‘s Venclyxto on NHS. Besides the price, the......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Here’s What’s Important About The Latest AbbVie Inc (ABBV) Approval

AbbVie Inc (NYSE:ABBV) just announced that it has picked up approval for one of its lead development candidates, but the company has failed to really......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Emergent Technologies’ Pure MHC Explores A New Collaboration With AbbVie Inc (ABBV)

AbbVie Inc (NYSE:ABBV) has sought a joint venture with its target discovery portfolio company, Emergent Technologies Inc, Pure MHC. The collaboration......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over Price Hikes

A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations. The bill seeks to shed......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AbbVie Inc (ABBV) Awaits NDA Approval For Hepatitis C Treatment

A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Gilead Sciences, Inc. (GILD) Takes Lead Against AbbVie Inc (ABBV) On Crohn’s Disease Treatment

Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (......(read more)
stock, trading, market, trader, traders, investor, investment, screen, bank, banking, share, broker, graph, business, chart, index, data, information, capital, team, money,

December 2016 Stock Considerations

The final ‘stock considerations’ post of 2016 is finally at hand. At the beginning of the year it’s sometimes hard to imagine what the next twelve......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AbbVie Inc (ABBV) Wins Patent Battle Against Coherus Biosciences Inc (CHRS)

The US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) has decided not to embark on the review of the 166 formulation patent......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AbbVie Inc (ABBV) Stock: Skyrocketing On IP Chatter | Coherus Biosciences Inc (CHRS) Stock Tanking

AbbVie Inc (NYSE:ABBV) and Coherus Biosciences Inc (NASDAQ:CHRS) were both off to a relatively normal start in the market today. While both were trading......(read more)
stock, trading, market, trader, traders, investor, investment, screen, bank, banking, share, broker, graph, business, chart, index, data, information, capital, team, money,

November 2016 Stock Considerations

As we near the home stretch of 2016 it seems like Mr. Market wants to give us some better buying opportunities compared to the recent months that have......(read more)
Best Bumble Bios For Girls

Four Dividend Champions On Sale

I usually look at dividend growth stocks and their dividend increases every week, as part of my portfolio monitoring process. In this weekly review,......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AbbVie Inc (ABBV) Expected To Launch Zinbryta In The US This Month

AbbVie Inc (NYSE:ABBV) and Biogen Inc (NASDAQ:BIIB) drug Zinbryta was approved by the Food and Drug Administration (FDA) as a therapy for adults suffering......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Finding Reliable 3%+ Dividends in Today’s Market: AbbVie Inc (ABBV)

Today, long term investors are challenged in navigating the course and lining up that long drive for a investment that will provide them a better than......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AbbVie Inc (ABBV): A Cheap Dividend Aristocrat Yielding Over 4%

AbbVie Inc (NYSE:ABBV) is one of the more controversial dividend aristocrats for several reasons. As a relatively new spin-off (2013), the company has......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Dividend Aristocrats Part 47: AbbVie Inc (ABBV)

AbbVie Inc (NYSE:ABBV) ranks very highly using The 8 Rules of Dividend Investing. The company’s stock has: – A 3.9% dividend yield – An......(read more)